Associate Professor, Medicine, University of Colorado School of Medicine
Pulmonology
Dr. Russell Bowler, MD
|
|
Give Review
Dr. Russell Bowler practices Pulmonology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. Russell Bowler has written publications. He has 65 publications published with PubMed. The lastest paper is: 'Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.' He is registered with Medicare and accepts Medicare payments.
Publications
- Understanding the impact of second-hand smoke exposure on clinical outcomes in participants with COPD in the SPIROMICS cohort.
- The beneficial effects of exercise on cartilage are lost in mice with reduced levels of ECSOD in tissues.
- Reduced Bone Density and Vertebral Fractures in Smokers: Men and COPD Patients at Increased Risk.
- Relationships between diffusing capacity for carbon monoxide (DLCO), and quantitative computed tomography measurements and visual assessment for Chronic obstructive pu...
- Plasma Sphingolipids Associated with COPD Phenotypes.
- Smoking Associated Site Specific Differential Methylation in Buccal Mucosa in the COPDGene Study.
- Pneumothorax Risk Factors in Smokers with and without Chronic Obstructive Pulmonary Disease.
- Menthol cigarette smoking in the COPDGene cohort: Relationship with COPD, comorbidities and CT metrics.
- Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics.
- Integrative omics approach identifies interleukin-16 as a biomarker of Emphysema.
- Circulating Hematopoietic Progenitor Cells are Decreased in COPD.
- MSPrep--Summarization, normalization and diagnostics for processing of mass spectrometry-based metabolomic data.
- The association of adiponectin with computed tomography phenotypes in Chronic obstructive pulmonary disease.
- N-Acetylcysteine Protects Murine Alveolar Type II Cells from Cigarette Smoke Injury in a Nuclear Erythroid 2-Related Factor-2-Independent Manner.
- Computed Tomographic Measures of Pulmonary Vascular Morphology in Smokers and their Clinical Implications.
- Peripheral Blood Mononuclear Cell Gene Expression in Chronic Obstructive Pulmonary Disease.
- Differences in Adjustment between Individuals with Alpha-1 Antitrypsin Deficiency (AATD)-Associated COPD and Non-AATD COPD.
- GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
- A Novel Function of MUC18: Amplification of Lung Inflammation during Bacterial Infection.
- COPD is associated with production of autoantibodies to a broad spectrum of self-antigens, correlative with disease phenotype.
- Superoxide Dismutase Mimetic, MnTE-2-PyP, Attenuates Chronic Hypoxia-Induced Pulmonary Hypertension, Pulmonary Vascular Remodeling, and Activation of the NALP3 Inflamm...
- Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes Pseudomonas aeruginosa Infection.
- IL-13 dampens human airway epithelial innate immunity through induction of IL-1 receptor-associated kinase M.
- Thromboxane receptor signaling is required for fibronectin-induced matrix metalloproteinase 9 production by human and murine macrophages and is attenuated by Arhgef1.
- Involvement of ceramide in cell death responses in the Pulmonary circulation.
- Plasma Antioxidants Are Associated with Impaired Lung Function and COPD Exacerbations in Smokers.
- Smoking and COPD increase sputum levels of extracellular superoxide dismutase.
- Peripheral Blood Mononuclear Cell Profiling in Tobacco Exposure: Susceptibility Markers for COPD.
- Up-Regulation of MUC18 in Airway Epithelial Cells by IL-13: Implications in Bacterial Adherence.
- Bronchial Secretory IgA Deficiency Correlates With Airway Inflammation and Progression of COPD.
- Endogenous enzymes (NOX and ECSOD) regulate smoke-induced oxidative stress.
- Family factors are associated with psychological distress and smoking status in Chronic obstructive pulmonary disease.
- Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA.
- Extracellular superoxide dismutase haplotypes are associated with acute Lung injury and mortality.
- Superoxide dismutase 3 polymorphism associated with reduced Lung function in two large populations.
- Phenotypes of Chronic obstructive pulmonary disease.
- N-acetylcysteine and exacerbations of Chronic obstructive pulmonary disease.
- Proteomics in Pulmonary medicine.
- Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for Chronic obstructive pulmonary disease.
- Induction of antioxidant gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species.
- Targeting vascular injury using Hantavirus-pseudotyped lentiviral vectors.
- Surface enhanced laser desorption/ionization (SELDI) time-of-flight mass spectrometry to identify patients with Chronic obstructive pulmonary disease.
- Lung inflation with direct injection of agarose: a technique for simultaneous molecular and morphometric measurements.
- Extracellular superoxide dismutase attenuates lipopolysaccharide-induced neutrophilic inflammation.
- Colocalization of eNOS and the catalytic subunit of PKA in endothelial cell junctions: a clue for regulated NO production.
- Proteomic analysis of Pulmonary edema fluid and plasma in patients with acute lung injury.
- Physiologic correlates of distal lung inflammation in Asthma.
- Airway antioxidants and oxidative stress as predictors of sputum atypia and airflow obstruction.
- Extracellular superoxide dismutase (EC-SOD) binds to type i collagen and protects against oxidative fragmentation.
- Oxidative stress in the pathogenesis of Asthma.
- The role of oxidative stress in Chronic obstructive pulmonary disease.
- Pulmonary edema fluid antioxidants are depressed in acute lung injury.
- Evidence for extracellular superoxide dismutase as a mediator of hemorrhage-induced Lung injury.
- Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal Failure.
- Oxidative stress in airways: is there a role for extracellular superoxide dismutase?
- A catalytic antioxidant (AEOL 10150) attenuates expression of inflammatory genes in stroke.
- Oxidative stress in allergic respiratory Diseases.
- Furin proteolytically processes the heparin-binding region of extracellular superoxide dismutase.
- Role of extracellular superoxide dismutase in bleomycin-induced Pulmonary fibrosis.
- Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort.
- Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans.
- The association of plasma biomarkers with computed tomography-assessed Emphysema phenotypes.
- Transient and Persistent Metabolomic Changes in Plasma following Chronic Cigarette Smoke Exposure in a Mouse Model.
- Trolox contributes to Nrf2-mediated protection of human and murine primary alveolar type II cells from injury by cigarette smoke.
Schools
University Of California San Francisco School Of Medicine
University Of California San Francisco School Of Medicine Program
University Of Colorado University Hospital Program
Procedures Preformed
- Ventilation Management
Conditions Treated
- Alkalosis
- Asthma
- Atelectasis
- Bronchiectasis
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
Accepted Insurances
Education
-
University of Colorado -
UCSF -
University of California San Francisco School of Medicine
Hospital
-
National Jewish Health -
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1073524856 | |
| NPPES Provider LastName | BOWLER | |
| NPPES Provider FirstName | RUSSELL | |
| NPPES Provider ZIPCode | 802062761 | |
| NPPES Provider State | CO | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 685.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073524856 |
| Last Name Of The Provider | BOWLER |
| First Name Of The Provider | RUSSELL |
| View All |
Similar Doctors
|
Dr. Cristian T. Arvinte, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rebecca L. Mortenson-Meese, MD |
|
|
Dr. Kelly Newton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy R. Collins, MD |
|
|
Dr. Timothy M. Clark, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Stubenrauch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nabeel Y. Hamzeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andras A. Bodoni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth L. Aronsen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Walter D. Conwell, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert J. Mason, MD |
|
|
Dr. James H. Ellis Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Sandhaus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James T. Good Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James P. Woodrow, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ivor S. Douglas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheila C. Tsai, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amen Sergew, MD
This Doctor is OpenDoctor Recommended.
|